Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches
Concurrently, leishmaniasis and AIDS are global public health issues and the overlap between these diseases adds additional treats to the management of co-infected patients. Lopinavir (LPV) has a well characterized anti-HIV and leishmanicidal action, and to analyze its combined action with miltefosi...
Main Authors: | Karina M. Rebello, Valter V. Andrade-Neto, Claudia Regina B. Gomes, Marcos Vinícius N. de Souza, Marta H. Branquinha, André L. S. Santos, Eduardo Caio Torres-Santos, Claudia M. d'Avila-Levy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2019.00229/full |
Similar Items
-
Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes
by: Fernanda de Aquino Marinho, et al.
Published: (2011-06-01) -
Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
by: Fabio dos Santos Nogueira, et al.
Published: (2019-02-01) -
PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
by: Patrícia de Almeida Machado, et al.
Published: (2021-01-01) -
Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
by: Lieselotte Van Bockstal, et al.
Published: (2020-08-01) -
Human immunodeficiency virus/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010
by: Iúri Paz Lima, et al.
Published: (2013-09-01)